Chronic hepatitis D virus (HDV) coinfection in people with chronic hepatitis B is associated with rapid progression to liver cirrhosis and high mortality. In 2020, the estimated global HDV burden ...

People who have had COVID-19 are more likely to develop chronic fatigue syndrome, officially known as myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). That’s according to a study published ...

Aligos Therapeutics is a clinical-stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases. The company is dedicated to educating ...

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase 3 AZURE-1 study and completion of screening in the Phase 3 AZURE-4 ...

"HDV should not be managed as a uniform condition. Sex-related differences matter." — Loreta A. Kondili, MD, National Center for Global Health, Italian Institute of Health, Rome “HDV is the most ...

In the most rigorous trial to date, oral silymarin was not superior to placebo in decreasing disease activity. Silymarin is a botanical extract of milk thistle commonly used by patients with liver ...

One of the most common viruses in the world, Epstein-Barr virus, or EBV is a member of the herpes virus family, also known as herpesvirus 4. Herpes viruses have been with humans for a very, very long ...

An infection with Epstein-Barr virus is a nonevent for most people. But for a subset, the virus can contribute to chronic conditions and cancer, and genes may play a role in that risk. When you ...

Nearly all adults carry Epstein–Barr virus—but new research reveals how it can hijack immune cells, sparking a chronic disease that attacks the body from within. This colorized transmission electron ...

Chronic hepatitis D coinfection affects an estimated 12 million people globally, with higher prevalence in low-income and middle-income countries, especially the African and Western Pacific regions.